ExtendicareEXETF +5.14%76 Receivables Turnover is 5.32 as of Mar. 2026. GuruFocus rates EXETF with a GF Score™ of 76/100 and a GF Value™ of $9.99 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Extendicare ranks better than 82.65% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Extendicare's Revenue for the
three
months ended in Mar. 2026 was $339 Mil. Extendicare's average Accounts Receivable for the
three
months ended in Mar. 2026 was $64 Mil.
Hence, Extendicare's Receivables Turnover for the
three
months ended in Mar. 2026 was 5.32.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Extendicare Receivables Turnover Related Terms
Extendicare Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Extendicare's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EXETF vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Extendicare's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Extendicare Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Extendicare's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Extendicare (EXETF) has a Receivables Turnover of 5.32 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Extendicare and its competitors. According to the industry distribution chart, Extendicare ranks #114 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 17.4%.
Is Extendicare's Receivables Turnover too high?
Extendicare's current Receivables Turnover is 5.32. The Healthcare Providers & Services industry median Receivables Turnover is 7.68. Extendicare's value of 5.32 is 30.7% below this industry median. Based on the distribution chart, Extendicare ranks #114 out of 657 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Extendicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Extendicare ranks #114 out of 657 companies for Receivables Turnover. This places Extendicare in the top 17% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.68. Extendicare's value of 5.32 is 30.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.68, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Extendicare's current Receivables Turnover of 5.32 is 30.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Extendicare and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Extendicare's current Receivables Turnover is 5.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.99, compared to a current price of $25.78 — trading 158.1% above its estimated fair value. The current Receivables Turnover is 5.32 and 30.7% below the Healthcare Providers & Services industry median of 7.68. Extendicare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Extendicare (EXETF), the current Receivables Turnover is 5.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Extendicare (EXETF) Overvalued in 2026?
Based on GuruFocus' analysis, Extendicare stock appears to be overvalued.
The current stock price of $25.78 is trading 158.1% above its estimated GF Value™ of $9.99.
GuruFocus considers Extendicare to be Significantly Overvalued.
Key valuation signals for EXETF:
Receivables Turnover: 5.32
GF Value™: $9.99 vs. price of $25.78 (158.1% above fair value)
Industry Position: 30.7% below the Healthcare Providers & Services median (#114 of 657)
No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
76GF Score
Get the complete analysis for EXETF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EXETF has been successfully added to your 
